BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7951413)

  • 1. Regulation of the expression of prostatic acid phosphatase in LNCaP human prostate carcinoma cells.
    Lin MF; Garcia-Arenas R; Kawachi M; Lin FF
    Cell Mol Biol Res; 1993; 39(8):739-50. PubMed ID: 7951413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human prostatic acid phosphatase activity and the growth of prostate carcinoma cells.
    Lin MF; DaVolio J; Garcia-Arenas R
    Cancer Res; 1992 Sep; 52(17):4600-7. PubMed ID: 1380886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
    Igawa T; Lin FF; Rao P; Lin MF
    Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential responsiveness of prostatic acid phosphatase and prostate-specific antigen mRNA to androgen in prostate cancer cells.
    Lin MF; Lee MS; Garcia-Arenas R; Lin FF
    Cell Biol Int; 2000; 24(10):681-9. PubMed ID: 11023645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of cellular prostatic acid phosphatase increases tumorigenicity of human prostate cancer cells.
    Lin MF; Lee MS; Zhou XW; Andressen JC; Meng TC; Johansson SL; West WW; Taylor RJ; Anderson JR; Lin FF
    J Urol; 2001 Nov; 166(5):1943-50. PubMed ID: 11586265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of a 185 kDa phosphoprotein (pp185) inversely correlates with the cellular activity of human prostatic acid phosphatase.
    Lin MF; Meng TC
    Biochem Biophys Res Commun; 1996 Sep; 226(1):206-13. PubMed ID: 8806615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prostatic acid phosphatase expression and secretion by androgen in LNCaP human prostate carcinoma cells.
    Lin MF; Garcia-Arenas R; Chao YC; Lai MM; Patel PC; Xia XZ
    Arch Biochem Biophys; 1993 Jan; 300(1):384-90. PubMed ID: 8424672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
    Henttu P; Vihko P
    Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liprin-alpha2 gene, protein tyrosine phosphatase LAR interacting protein related gene, is downregulated by androgens in the human prostate cancer cell line LNCaP.
    Fujinami K; Uemura H; Ishiguro H; Kubota Y
    Int J Mol Med; 2002 Aug; 10(2):173-6. PubMed ID: 12119554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of cell density on androgen regulation of the mRNA level of human prostatic acid phosphatase.
    Lin MF; Garcia-Arenas R
    Mol Cell Endocrinol; 1994 Mar; 99(2):R21-4. PubMed ID: 8206318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C pathway is involved in regulating the secretion of prostatic acid phosphatase in human prostate cancer cells.
    Lin MF; Zhang XQ; Dean J; Lin FF
    Cell Biol Int; 2001; 25(11):1139-48. PubMed ID: 11913958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
    Lin MF; Meng TC; Rao PS; Chang C; Schonthal AH; Lin FF
    J Biol Chem; 1998 Mar; 273(10):5939-47. PubMed ID: 9488733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone extracellular matrix induces homeobox proteins independent of androgens: possible mechanism for androgen-independent growth in human prostate cancer cells.
    Robbins SE; Shu WP; Kirschenbaum A; Levine AC; Miniati DN; Liu BC
    Prostate; 1996 Dec; 29(6):362-70. PubMed ID: 8977633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of receptor protein tyrosine phosphatase alpha mRNA in human prostate cancer cell lines.
    Zelivianski S; Dean J; Madhavan D; Lin FF; Lin MF
    Mol Cell Biochem; 2000 May; 208(1-2):11-8. PubMed ID: 10939623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
    Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular level of prostatic acid phosphatase and the growth of human prostate carcinoma cells.
    Lin MF; Garcia-Arenas R; Xia XZ; Biela B; Lin FF
    Differentiation; 1994 Aug; 57(2):143-9. PubMed ID: 8070625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.
    Meng TC; Lee MS; Lin MF
    Oncogene; 2000 May; 19(22):2664-77. PubMed ID: 10851066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP.
    Swinnen JV; Esquenet M; Goossens K; Heyns W; Verhoeven G
    Cancer Res; 1997 Mar; 57(6):1086-90. PubMed ID: 9067276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of regulatory elements of the human prostatic acid phosphatase promoter.
    Zelivianski S; Igawa T; Lim S; Taylor R; Lin MF
    Oncogene; 2002 May; 21(23):3696-705. PubMed ID: 12032838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and analysis of the promoter activity of the human prostatic acid phosphatase gene.
    Zelivianski S; Comeau D; Lin MF
    Biochem Biophys Res Commun; 1998 Apr; 245(1):108-12. PubMed ID: 9535792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.